Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
27.61
-0.55%
After-hours: Aug 15, 2025, 07:52 PM EDT

Apellis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-197.88M -528.63M -652.17M -746.35M
Depreciation & Amortization
1.8M 1.7M 1.49M 1.49M
Stock-Based Compensation
114.13M 105.94M 91.08M 70.67M
Other Working Capital
49.79M -200.34M 32.63M -77.59M
Other Non-Cash Items
12.44M 26.41M 61.55M 6.33M
Deferred Income Tax
n/a n/a n/a 198.26M
Change in Working Capital
-18.36M -200.17M -15.7M -93.52M
Operating Cash Flow
-87.87M -594.74M -513.75M -563.13M
Capital Expenditures
-403K -773K -1.52M -1.1M
Cash Acquisitions
n/a n/a -61.42M -248.72M
Purchase of Investments
n/a n/a -331.86M -171.28M
Sales Maturities Of Investments
n/a n/a 393.28M 420M
Other Investing Acitivies
n/a 99K 61.42M 248.72M
Investing Cash Flow
-403K -674K 59.89M 247.62M
Debt Repayment
365.45M n/a n/a n/a
Common Stock Repurchased
4.51M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-216.21M 10.11M -14.46M 11.87M
Financial Cash Flow
149.24M 394.5M 365.66M 392.24M
Net Cash Flow
60.31M -200.78M -88.68M 74.71M
Free Cash Flow
-88.27M -595.51M -515.27M -564.23M